Skip to main content
Premium Trial:

Request an Annual Quote

NCI Awards Insightful $186K to Develop Cancer Prevention Research Software

NEW YORK, Feb. 7 (GenomeWeb News) - The National Cancer Institute has awarded Insightful two contracts worth a total of $185,807 to develop advanced bioinformatics software to analyze and evaluate proteomic cellular signatures in cancer prevention research, Insightful said today.


The software will use Insightful's S-Plus 7 and S+ArrayAnalyzer products, the company said.


The initial contracts call for solutions to the "challenges of preprocessing mass spectrometry data," Insightful said. The company is planning to develop software that includes calibration, denoising, baseline detrending, intensity normalization, peak detection, alignment, feature selection and extraction, as well as graphics.


Insightful said the funding will be recorded in the company's financial statements as a reduction to research and development expense.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.